Immediate Impact
47 standout
Citing Papers
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 Standout
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
Works of Ann Tan being referenced
Safety and Feasibility of Using Sorafenib in Recurrent Hepatocellular Carcinoma after Orthotopic Liver Transplantation
2010
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Ann Tan | 93 | 59 | 29 | 97 | 69 | 16 | 231 | |
| Fan Zhang | 38 | 78 | 38 | 79 | 49 | 14 | 238 | |
| Kunal Jain | 60 | 66 | 21 | 83 | 21 | 22 | 193 | |
| Xuqi Sun | 69 | 65 | 21 | 108 | 183 | 27 | 263 | |
| Beatriz García-Paredes | 54 | 66 | 36 | 175 | 43 | 18 | 242 | |
| Supriya Chopra | 159 | 87 | 34 | 169 | 17 | 18 | 281 | |
| Jen-Fu Yang | 70 | 80 | 26 | 70 | 142 | 19 | 260 | |
| Ying Zhou | 52 | 62 | 13 | 14 | 46 | 17 | 161 | |
| Georges Garnier | 48 | 59 | 44 | 94 | 12 | 15 | 210 | |
| Andrea Tufo | 158 | 127 | 29 | 180 | 60 | 20 | 299 | |
| Songqiang Zhou | 73 | 76 | 32 | 105 | 163 | 15 | 273 |
All Works
Loading papers...